We evaluated positron emission tomographic imaging of pulmonary transgene expression, using an enhanced mutant Herpes Simplex Virus-1 thymidine kinase as the reporter gene, in the lungs of normal rats. Sixteen rats were studied 3 days after intratracheal administration of 5×10 9 -1×10 11 viral particles of a replication-incompetent adenovirus containing a fusion gene of the mutant kinase and green fluorescent protein.
Introduction
Despite daunting challenges and setbacks, prospects remain strong that pulmonary gene therapy will eventually become part of the routine therapeutic armamentarium.
While gene therapy was initially proposed as a curative approach for inherited monogenic diseases, like cystic fibrosis and alpha-1-antitrypsin deficiency, recent experimental studies have shown that acute illnesses might also benefit from gene transfer therapy (1) .
For instance, a transgene encoding the heat shock protein-70 has been successfully transferred to rat lungs after the onset of experimental lung injury, significantly decreasing lung interstitial and alveolar edema, neutrophilic accumulation in the lungs, and mortality (2) . Detecting gene expression in the lungs has been especially difficult and progress in the field of gene therapy in general will ultimately depend on appropriate clinical methods to evaluate the distribution, magnitude and timing of transgene expression. Although in situ hybridization techniques, immunohistochemical procedures and several reporter genes can be used to monitor gene expression in tissue biopsy samples, these methods are invasive and unattractive as routine procedures for clinical evaluation.
Recent advances in imaging technologies make non-invasive visualization of in vivo reporter gene expression possible. Non-invasive real-time analysis of gene expression is possible using reporter genes with optical signatures (e.g. green fluorescent protein (gfp) (3), firefly luciferase (4), and bacterial luciferase). However, spatial resolution is poor, and their use at present is limited to small animals. Gene expression imaging with magnetic resonance (MR) has been described but this approach is not suitable for lung studies since the proton density of the lung parenchyma is too low to generate an MR image (5) . On the other hand, radiotracer imaging offers the possibility of monitoring the detailed location, magnitude and persistence of reporter gene expression, even clinically. Among these methods, positron emission tomography (PET) imaging has the greatest sensitivity and isotropism, and its usefulness as a method for gene expression imaging has been further enhanced by the development of dedicated small animal PET scanners (6) .
Recent studies have shown that PET can be used to detect reporter proteins such as the herpes simplex virus type-1 thymidine kinase (HSV1-TK) in vivo (7, 8 (8, 9) have been developed to further improve the sensitivity of PET imaging to detect and quantify the cellular accumulation of these radioactive tracers. The present study was performed to demonstrate that these techniques can be used to detect the expression of genes delivered to the lungs by viral vectors.
Cell culture studies
HeLa cells were infected with various viral titers (1×10 7 -1×10 9 viral particles (VP)) of a human type 5 replication deficient (E1a/E3 deleted) adenovirus (Ad), containing a fusion gene of mHSV1-tk and gfp (8) , driven by the cytomegalovirus promoter (Ad-CMV-mNLS-sr39tk-egfp). An Ad containing no insert (AdCMVnull) served as control.
The cells were harvested 48 hours later for quantitation of mHSV1-TK activity and GFP expression by ELISA.
Adenovirus infection protocol
This study was approved by the Washington University School of Medicine's Animal
Studies Committee and performed on 19 Sprague-Dawley rats (mean weight ± SD = 280 ± 70 g). 16 rats were infected with various viral doses ranging from 5×10 9 to 1×10 11 viral particles (VP) of AdCMV-mNLS-sr39tk-egfp. A control group (n = 3 rats) was infected with a sham vector (AdCMVnull). All adenovirus delivery to rat lungs was performed using a surfactant-based method (10, 11) .
PET studies
FHBG was synthesized as previously described (12) . PET imaging was performed on a microPET-R4 camera (13, 14) . Rats were anesthetized with isoflurane shortly before bolus injection of 1. 
Tissue retrieval protocol
Immediately after PET scanning was completed, rats were euthanized. Lungs were harvested, immediately frozen and later processed for mHSV1-TK enzyme activity (right middle lobe) and GFP levels by ELISA (right lower lobe). Radioactivity in the left lung was measured in a gamma counter, decay corrected to the beginning of the PET scan and normalized to the [ 18 F]FHBG ID. The result was expressed as the %ID/gm lung. After fixation, the left lung was cryosectioned and studied by fluorescence microscopy. (15, 16) .
mHSV1-TK enzyme assay

GFP quantitation with ELISA
Protein extracts were incubated in microplates coated with goat anti-GFP antibody, and bound protein was detected by horseradish peroxidase-conjugated anti-GFP antibody.
The GFP levels were quantified using a spectrophotometer and normalized by protein concentration of each sample.
Statistical analysis
Regression analyses were performed by the least squares method and correlations
were assessed with Pearson's correlation co-efficient. Comparisons among groups were performed by ANOVA or ANOVA on ranks. For additional pairwise comparisons, Dunn's test was performed. The level of significance was set at p < 0.05.
Results
In vitro mHSV1-TK activity, measured in cell culture after transfection with Ad vector, showed a highly linear correlation with viral dose (Figure 2A ). GFP expression by ELISA showed a similarly strong correlation with viral dose (R 2 = 0.997, data not shown). As a result, both measures of mHSV1-tk and gfp expression were also highly correlated to one another ( Figure 2B ). Comparable results were found when correlating measurements of mHSV1-TK activity and GFP expression from lung tissue samples 
Discussion
This study demonstrates that PET imaging after iv administration of [ 18 F]FHBG is capable of detecting even low levels of mHSV1-tk gene expression in rat lungs. This finding suggests that such methods could be used as a non-invasive reporter system to detect and monitor the effectiveness of therapeutic gene transfer to the lungs, a conclusion supported by the simultaneous and similar correlations between the PET imaging signal on the one hand, and the in vitro measures of both mHSV1-TK enzyme activity and GFP levels on the other.
Methodological issues
Several PET gene reporter systems have been described, each with their own advantages and drawbacks, as discussed in several recent review articles (17, 18, 19) . In general, two strategies have been proposed. One is based on the transfer of genes encoding membrane-bound receptors, such as the dopamine-2 receptor (20) , not normally expressed in a particular tissue. PET imaging is then used to detect specific binding of a suitable radiolabeled ligand for that receptor.
The other major approach, such as used in this study, is enzymatic (16, 21) . In this case, gene transfer results in the expression of an enzyme which can metabolize a radiolabeled substrate in such a way that the metabolized form is trapped intracellularly.
This strategy offers the advantage of signal amplification, since a single copy of the enzyme can metabolize -and trap -many molecules of substrate. However, transmembrane transport of the radiolabeled substrate is also required -which is a factor of potential importance (see below). To date, HSV1-tk is the most extensively studied enzymatic PET reporter system (8, 16, 21, 22, 23) , with studies showing that successful gene transfer to liver, tumor xenografts, and heart could be detected in mice after iv adenoviral vector administration. In addition, recent studies of this system have employed more efficient mutant forms of HSV1-tk, capable of even greater amplification of substrate accumulation (leading to improved PET imaging sensitivity). In the current study, we used a newly engineered mutant HSV1-tk gene (8) to provide the first demonstration that this general strategy for "gene expression imaging" could be used to monitor gene transfer to lung tissue.
Various radiolabeled substrates have also been evaluated as HSV1-tk PET reporter Of course, any possibility that PET imaging can be used to measure transgene expression will depend on the accuracy of PET devices to quantify tissue radioactivity.
While an extensive empirical experience substantiates the accuracy of PET in general (25) , studies employing the "microPET" generation of scanners are still limited. In the present study, Figure 4 shows that a strong linear correlation exists between the radioactivity measurements obtained from imaging data and direct measurements of In this study, transgene expression was confined virtually entirely to the lung parenchyma as a result of administering viral vector with a surfactant based method (10, 11) . However, given the relatively limited spatial resolution of PET imaging (several mm), it is unlikely that imaging by itself would be able to discriminate expression at different tissue levels within the lungs (e.g. airway epithelium or microvessel endothelium). Accordingly, we anticipate that correlation studies with adjunctive methods, such as GFP fluorescence microscopy as used in this study, will continue to be necessary.
PET sensitivity to detect mHSV1-TK activity in the lungs
In this study, the PET signal was significantly increased above background (as assessed by imaging after null vector administration) in animals infected by low as well as high doses of adenoviral vector ( Figure 5 ). This was not the case with either in vitro assay of mHSV1-TK enzyme activity or GFP levels, in which gene expression was barely detected at the lower viral doses. This apparent higher sensitivity of PET imaging, in comparison to either in vitro technique, is quite plausible since radionuclide-based methods should be able to detect very low levels of reporter probe accumulation (18), as low as 10 -12 mol/L of radiolabeled substrate (28) .
Relationship between PET signal and in vitro assays of mHSV1-TK activity
Optimally, to monitor transgene expression, PET imaging must not only yield accurate measurements of tissue radioactivity, but measurements that are closely related to tissue levels of the gene product. Some studies have reported a highly linear correlation between the PET signal and in vitro assays of transgene expression (21, 23, 29) , at least at low levels of mHSV1-tk expression. More recently, however, the possibility that the PET signal may become saturated at high mHSV1-tk expression levels has been raised (16), because cellular entry of the radiolabeled substrates requires potentially saturable nucleosides transporters (23, 24, 30, 31, 32 
Clinical implications
In this study, we describe a non-invasive imaging strategy that can be used to detect, quantify, and describe the spatial distribution of transgene expression within the lungs.
Thus, with systems like the one employed in this study, it should be possible to monitor the onset and duration of transgene therapies non-invasively over time. Recent advances in transgene vectors as well as improvements in promoter technology have expanded the potential application of gene transfer therapy from inherited monogenic to acute diseases (1). Thus, a wide variety of lung diseases are potentially treatable by gene therapy, including pulmonary hypertension (33) , cystic fibrosis, and the acute respiratory distress syndrome (2, 10), among others. The PET reporter system described in this study should be viewed as a "first generation" system, one that will undoubtedly improve as alternative reporter genes, probes, and PET instruments are developed and evaluated. Nevertheless, the potential value of such a system in both experimental and clinical studies is obvious.
Even current generation "microPET" systems (as used herein) are able to detect and quantify transgene expression in murine models, thereby permitting studies in already available genetic models of disease. In addition, the possibility that this imaging strategy can be deployed clinically has been advanced by a recent report documenting the safety of [ 18 F]FHBG administration to healthy volunteers (34) . Ultimately, however, it will not
only be important to demonstrate robust correlations between reporter gene and therapeutic gene expression, but also to document that such expression -as evaluated by imaging -has a predictable relationship to the intended physiologic effect of the therapeutic transgene.
Conclusion
PET imaging is a sensitive and quantitative method for detecting pulmonary reporter gene expression non-invasively. The cells were then exposed to adenovirus for 48 hours and were then harvested for quantitation of thymidine kinase activity and green fluorescent protein (GFP) expression by enzyme-linked immunosorbent assay (ELISA) (see below).
Adenovirus infection protocol
The present study was approved by the Washington University School of Medicine's Animal Studies Committee and performed on 19 Sprague-Dawley rats (mean weight ± SD = 280 ± 70 g, age ranging from 49 to 75 days), assigned to two experimental groups:
a control group (n = 3 animals) in which the rats were infected with AdCMVnull (1 × Rats were then allowed to recover prior to extubation. Infected animals were maintained in separate isolator cages until time for the PET study.
PET study 
mHSV1-TK enzyme assay
Details of this assay have been described previously (E10 
GFP quantitation with ELISA
Protein extracts from HeLa cells or lung samples were incubated in microplates coated with goat anti-GFP antibody (Reacti-bind ™ anti-GFP coated plates, Pierce biotechnology, Rockford, IL, USA), and bound protein was detected by horseradish peroxidase-conjugated affinity purified anti-GFP antibody (Rockland Immunochemicals, Gilbertsville, PA, USA). Absorbance at 450 nm was measured to detect horseradish peroxidase activity in the protein extracts and to generate a linear standard curve using serial dilutions of known amount of GFP from 1.5 to 100 ng/ml. The GFP levels in the samples were quantified within the linear range of the standard curve and normalized by the protein concentration of each sample, measured by the Bio-Rad protein assay (BioRad laboratories, Hercules, CA, USA).
Fluorescence microscopy
Distribution of fluorescence on lung cryosections was analyzed on a BX51 Olympus microscope (Olympus optical CO, ltd., Tokyo, Japan), coupled with a digital imaging camera (Magnafire, Optronics, Goleta, CA, USA), connected to a PC. 
